Live tape
Top 8, mentions 7d14,365NVDA4,867 mentions▲ +0.04GOOGL2,064 mentions▲ +0.04SPY1,738 mentions▲ +0.06QQQ1,554 mentions▲ +0.05AMD1,212 mentions▲ +0.08SPCX1,112 mentions▲ +0.05TSLA956 mentions▲ +0.04SNDK862 mentions▲ +0.06

Equity · Healthcare

GDRX

NASDAQ

GoodRx Holdings (GDRX)

3.67 USD −1.61% vs prior close
GoodRx Holdings, Inc. price graph

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers.

Track this symbol on TradingView
Market cap
1.3B USD
P/E (TTM)
91.8
Revenue, year to Dec 2025
796.9M USD
EPS, diluted, year to Dec 2025
0.09 USD
52-week range
1.87 USD – 5.30 USD
Avg volume
302.9K

as of Aug 7, 2026

Have GoodRx Holdings (GDRX) insiders bought or sold shares recently?

In the 90 days to 10 Nov 2026, GoodRx Holdings insiders reported 6 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 8 Nov 2025, show no open-market purchase.

Form 4, 90 days to 10 Nov 2026, newest reported trade 26 Aug 2026

0buys
6sells
$9.68Mnet sold
18other filings
Have GoodRx Holdings (GDRX) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
26 Aug 2026FRANCISCO PARTNERS IV, L.P.10% OwnerSell1,296,1774.5M USD
25 Aug 2026FRANCISCO PARTNERS IV, L.P.10% OwnerSell127,273438K USD
24 Aug 2026FRANCISCO PARTNERS IV, L.P.10% OwnerSell143,594497K USD
21 Aug 2026FRANCISCO PARTNERS IV, L.P.10% OwnerSell274,717961K USD
20 Aug 2026FRANCISCO PARTNERS IV, L.P.10% OwnerSell447,2591.6M USD
19 Aug 2026FRANCISCO PARTNERS IV, L.P.10% OwnerSell471,9751.7M USD
Sold6 open-market sales2,760,995$9.68M
18 other filings in the window: grants, exercises, tax withholding and transfers, not trades
Have GoodRx Holdings (GDRX) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
08 Nov 2026Bruehlman Ronald EDirectorOption exercise21,692
02 Nov 2026Bezdek TrevorDirectorOption exercise34,975
26 Oct 2026Hirsch Douglas JosephDirectorOption exercise20,521
15 Oct 2026Barnes Wendy LynnSee RemarksOption exercise277,289
15 Oct 2026Barnes Wendy LynnSee RemarksTax withheld120,456407K USD
15 Oct 2026Chan Thomas (TC)Chief Accounting OfficerOption exercise5,793
15 Oct 2026Chan Thomas (TC)Chief Accounting OfficerTax withheld2,94810K USD
15 Oct 2026Fengler JustinSee RemarksOption exercise32,490
15 Oct 2026Fengler JustinSee RemarksTax withheld14,24748K USD
15 Sep 2026Chan Thomas (TC)Chief Accounting OfficerOption exercise2,101
15 Sep 2026Chan Thomas (TC)Chief Accounting OfficerTax withheld1,0694K USD
15 Sep 2026Fengler JustinSee RemarksOption exercise3,087

Showing the 12 most recent of 18 compensation filings in this window. The figures above count all of them.

Which funds hold GoodRx Holdings (GDRX)?

8 of the 45 institutional funds we track reported a GoodRx Holdings position for the quarter ended 30 Jun 2026 — a combined 22.5M USD; the latest of those filings landed 02 Sep 2026.

Form 13F

Which funds hold GoodRx Holdings (GDRX)?
FundPositionSharesValueShares q/q
Renaissance TechnologiesHeld (±25%)3,245,7389.3M USD−0.4%
AQR Capital ManagementAdded2,326,0806.7M USD+29.1%
Two Sigma InvestmentsAdded742,1812.1M USD+294.0%
Marshall WaceNew position543,0281.6M USD
D. E. Shaw & Co.Added477,7031.4M USD+53.0%
Millennium ManagementAdded356,6541.0M USD+1,302.7%
Citadel AdvisorsTrimmed104,218300K USD−54.2%
Point72 Asset ManagementNew position19,34256K USD
Balyasny Asset ManagementExited

What has been filed or recorded for GoodRx Holdings (GDRX)?

The filings we hold for GoodRx Holdings, newest first: 4 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 14 Oct 2026. No next earnings date is announced in SEC filings yet.

What has been filed or recorded for GoodRx Holdings (GDRX)?
And
14 Oct 2026Fails to deliverShares failed to deliver790 shares3K USD notional · <0.001% of shares out
13 Oct 2026Fails to deliverShares failed to deliver500 shares2K USD notional · <0.001% of shares out
08 Oct 2026Fails to deliverShares failed to deliver26 shares85 USD notional · <0.001% of shares out
07 Oct 2026Fails to deliverShares failed to deliver26 shares85 USD notional · <0.001% of shares out
30 Jun 2026Quarterly earningsQ2 2026 reportedEPS 0.02 USDRevenue $200M
30 Jun 2026FinancialsTotal assets2.3B USDat period end
30 Jun 2026FinancialsTotal equity647.6M USDat period end
31 Mar 2026Quarterly earningsQ1 2026 reportedEPS 0.00 USDRevenue $194M
31 Dec 2025Annual reportFY 2025 reportedEPS 0.09 USDRevenue $797M
31 Dec 2025FinancialsRevenue796.9M USDfiscal year
31 Dec 2025FinancialsNet income30.4M USDfiscal year
31 Dec 2025FinancialsDiluted EPS0.09 USDfiscal year
30 Sep 2025Quarterly earningsQ3 2025 reportedEPS 0.00 USDRevenue $196M
30 Jun 2025Quarterly earningsQ2 2025 reportedEPS 0.04 USDRevenue $203M
31 Mar 2025Quarterly earningsQ1 2025 reportedEPS 0.03 USDRevenue $203M
31 Dec 2024Annual reportFY 2024 reportedEPS 0.04 USDRevenue $792M
30 Sep 2024Quarterly earningsQ3 2024 reportedEPS 0.01 USDRevenue $195M

What do people ask about GoodRx Holdings (GDRX)?

From live data
What is GoodRx Holdings’ market cap?1.3B

GoodRx Holdings is worth 1.3B USD by market value as of 7 Aug 2026, which is the share price times the shares on issue from its SEC filings.

What is GoodRx Holdings’ P/E ratio?91.8

GoodRx Holdings has a price-to-earnings ratio of 91.8, as of 7 Aug 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.

What is GoodRx Holdings’ revenue?796.9M

GoodRx Holdings reported revenue of 796.9M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings

Have GoodRx Holdings insiders bought or sold shares recently?6 sales

In the 90 days to 10 Nov 2026, GoodRx Holdings insiders reported 6 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 8 Nov 2025, show no open-market purchase. A further 18 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders

Which funds own GoodRx Holdings?8 of 45

8 of the 45 funds we track reported a GoodRx Holdings position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Renaissance Technologies, AQR Capital Management and Two Sigma Investments. See Funds

When did GoodRx Holdings last report earnings?0.02

GoodRx Holdings last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of 0.02 USD; no next date is announced in SEC filings yet. See Filings

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close)
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARForm 4 filings (insider transactions)
  4. SEC EDGAR13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. SEC EDGARXBRL company facts, latest period ended 30 Jun 2026
  7. SEC EDGARreported earnings figures and scheduled report dates
  8. SEC EDGARValuation computed from SEC EDGAR filings